Evidence map›Paper›PMID 40296113›Full record

ArticleCell communication and signaling : CCS2025

Correction: A network-based approach to overcome BCR::ABL1-independent resistance in chronic myeloid leukemia.

Valeria Bica, Veronica Venafra, Giorgia Massacci, Simone Graziosi, Sara Gualdi, Gessica Minnella, Federica Sorà, Patrizia Chiusolo, Maria Elsa Brunetti, Gennaro Napolitano and 6 more

Abstract readPublished Erratum
In one paragraph

Article in Cell communication and signaling : CCS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Valeria Bica *Ph.D. Program in Cellular and Molecular Biology, Department of Biology, University of Rome 'Tor Vergata', Rome, Italy.
Veronica Venafra *Ph.D. Program in Cellular and Molecular Biology, Department of Biology, University of Rome 'Tor Vergata', Rome, Italy.
Giorgia MassacciDepartment of Biology, University of Rome Tor Vergata, Rome, Italy.
Simone GraziosiPh.D. Program in Cellular and Molecular Biology, Department of Biology, University of Rome 'Tor Vergata', Rome, Italy.
Sara GualdiDepartment of Biology and Biotechnologies "C. Darwin", University of Rome La Sapienza, Rome, Italy.
Gessica MinnellaSezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, Roma, Italy.
Federica SoràSezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, Roma, Italy.
Patrizia ChiusoloSezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, Roma, Italy.
Maria Elsa BrunettiTelethon Institute of Genetics and Medicine (TIGEM), Naples, Italy.
Gennaro NapolitanoTelethon Institute of Genetics and Medicine (TIGEM), Naples, Italy.
Massimo BrecciaDepartment of Translational and Precision Medicine, Azienda Policlinico Umberto I, Sapienza University of Rome, Rome, Italy.
Dimitrios MougiakakosHealth campus for Inflammation, Immunity and Infection (GCI3), University of Magdeburg, Magdeburg, Germany.
Martin BöttcherHealth campus for Inflammation, Immunity and Infection (GCI3), University of Magdeburg, Magdeburg, Germany.
Thomas FischerHealth campus for Inflammation, Immunity and Infection (GCI3), University of Magdeburg, Magdeburg, Germany.
Livia PerfettoDepartment of Biology and Biotechnologies "C. Darwin", University of Rome La Sapienza, Rome, Italy. livia.perfetto@uniroma1.it.
Francesca SaccoDepartment of Biology, University of Rome Tor Vergata, Rome, Italy. francesca.sacco@uniroma2.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40296113
PMCPMC12036233

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.